Journal of Cancer

短名J. Cancer
Journal Impact3.40
国际分区ONCOLOGY(Q2)
期刊索引SCI Q2中科院 3 区
ISSN1837-9664
h-index81
国内分区医学(3区)医学肿瘤学(4区)

JOURNAL OF CANCER 是一本开放获取、同行评审的期刊,范围广泛,涵盖癌症研究的所有领域,尤其是癌症早期检测和干预的新概念、新方法、新方案、新治疗剂和替代方法。该杂志由一个由杰出的癌症研究人员组成的国际编辑委员会提供支持。 JOURNAL OF CANCER 旨在快速发表高质量的癌症研究结果,同时保持严格的同行评审过程。

期刊主页投稿网址
涉及主题医学生物内科学遗传学癌症化学生物化学癌症研究病理基因肿瘤科外科免疫学数学统计细胞生物学细胞凋亡
出版信息出版商: Ivyspring International Publisher出版周期: 期刊类型: journal
基本数据创刊年份: 2010原创研究文献占比90.09%自引率:0.00%Gold OA占比: 99.70%
平均审稿周期 网友分享经验:12 Weeks

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

Synergistic Anti-Tumor Efficacy Achieved by Reversing Drug Resistance through the Regulation of the Tumor Immune Microenvironment with IL-12 and Osimertinib Combination Therapy

2024-1-1

MPP7 mediates EMT via Wnt/β-catenin pathway to promote polarity changes in epithelial ovarian cancer cells

2024-1-1

Prognostic Value and Immune Landscapes of Four Types of RNA Modification Writer-Related LncRNAs Signature in Lung Adenocarcinoma

2024-1-1

Integrated pan-cancer genomic analysis reveals the role of SLC30A5 in the proliferation, metastasis, and prognosis of hepatocellular carcinoma

2024-1-1

Genetic polymorphism of IL-18 influences susceptibility to lung cancer in population of eastern China

2024-1-1

N<sup>6</sup>-methyladenosine-modified circ_0006168 promotes epithelial mesenchymal transition via miR-384/STAT3/Snail axis in esophageal squamous cell carcinoma

2024-1-1

The combination of single-cell and RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genes

2024-1-1

Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer

2024-1-1

Lycorine inhibits migration and proliferation of hepatocellular carcinoma cells by reducing transketonase expression

2024-1-1

Survival-weighted quality of life profiles in patients treated for laryngeal and hypopharyngeal cancers

2024-1-1

Gene polymorphisms of <i>METTL5</i> and <i>METTL16</i> are related to epithelial ovarian cancer risk in South China: A three-center case-control study

2024-1-1

Clinical Implications of a Six-Protein Signature in Bone Metastasis of Renal Cell Carcinoma

2024-1-1

Multi-omics identification of GPCR gene features in lung adenocarcinoma based on multiple machine learning combinations

2024-1-1

AQP3 Promotes the Invasion and Metastasis in Cervical Cancer by Regulating NOX4-derived H<sub>2</sub>O<sub>2</sub> Activation of Syk/PI3K/Akt Signaling Axis

2024-1-1

MiRNA-766-3p inhibits gastric cancer via targeting COL1A1 and regulating PI3K/AKT signaling pathway

2024-1-1

Paraneoplastic Cutaneous Manifestations of Hepatocellular Carcinoma. A Systematic Review and Meta-analysis

2024-1-1

Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation

2024-1-1

A nomogram prediction model based on clinicopathological combined radiological features for metachronous liver metastasis of colorectal cancer

2024-1-1

EBUS-TBLC increase the diagnosis rate in different type of peripheral pulmonary lesions

2024-1-1

CircRNA_100395 inhibits cell proliferation and metastasis in ovarian cancer via regulating miR-1228/p53/epithelial-mesenchymal transition (EMT) axis: Erratum

2024-1-1

Optimization of stereotactic radiotherapy (SRT) planning for brain metastases from lung cancer by Cyberknife system: reducing dose distribution inner ear

2024-1-1

Single-cell RNA-Seq Elucidates the Crosstalk Between Cancer Stem Cells and the Tumor Microenvironment in Hepatocellular Carcinoma

2024-1-1

DNA Image Cytometry for Screening the Carcinogenetic Risk of Oral Potential Malignant Disorders

2024-1-1

Effectiveness and Safety of Chinese Herbal Injections Combined with SOX Chemotherapy Regimens for Advanced Gastric Cancer: a Bayesian Network Meta-Analysis

2024-1-1

FEN1 Promotes Hepatocellular Carcinoma Progression by Activating Cell Cycle Transition from G2 To M Phase

2024-1-1

The Role MicroRNA-135a in Suppressing Tumor Growth in Kidney Cancer Through the Regulation of Phosphoprotein Phosphatase2A and the Activation of the AKT and ERK1/2 Signaling Pathways

2024-1-1

Unraveling the Action Mechanism of Tubeimoside-1 against Tumor Microvessels via Network Pharmacology and Experimental Validation

2024-1-1

Nebulisation of Paclitaxel, Sotatercept and Iloprost for pulmonary hypertension for lung cancer. From <i>In vitro</i> to <i>In vivo</i>

2024-1-1

Butein inhibits oral squamous cell carcinoma growth via promoting MCL-1 ubiquitination

2024-1-1

Development of Polymeric Micelles for Combined Delivery of Luteolin and Doxorubicin for Cancer Therapy

2024-1-1

Occurrence and Prognosis of Mixed Subtype Adenocarcinoma and Adeno-Squamous Carcinoma in Esophageal Cancer

2024-1-1

PD-1/PD-L1 Inhibitor - Related Adverse Events and Their Management in Breast Cancer

2024-1-1

Glucose metabolism reprogramming in gynecologic malignant tumors

2024-1-1

Safety and Efficacy Analysis of Radical Surgery for 403 Patients with Colon Cancer over 80 Years Old

2024-1-1

Identification of the Expression of TIE1 and Its Mediated Immunosuppression in Gastric Cancer

2024-1-1

Postoperative subphenotypes modified the hepatoma arterial-embolization prognostic score: A novel smHAP-II nomogram

2024-1-1

Potential Role of MAP3K14 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis and Validation

2024-1-1

TRPV3 regulates Breast Cancer Cell Proliferation and Apoptosis by EGFR/AKT pathway

2024-1-1

Constructing a Prognostic Model of Uterine Corpus Endometrial Carcinoma and Predicting Drug-Sensitivity Responses Using Programmed Cell Death-Related Pathways

2024-1-1

Cell-free Nucleic Acid as Promising Diagnostic Biomarkers for Gastric Cancer: a Systematic Review

2024-1-1

Circular RNA Hsa_circRNA_101996 promotes the development of Gastric Cancer via Upregulating Matrix Metalloproteinases-2/Matrix Metalloproteinases-9 through MicroRNA-143/Ten-eleven translocation-2 Pathway: Erratum

2024-1-1

ASB6 as an Independent Prognostic Biomarker for Colorectal Cancer Progression Involves Lymphatic Invasion and Immune Infiltration

2024-1-1

Unraveling the role of the circadian clock genes in cervical squamous cell carcinoma and endocervical adenocarcinoma: A prognostic indicator for prognostic, immunotherapy response, and chemotherapy sensitivity

2024-1-1

Revisiting Temozolomide's role in solid tumors: Old is gold?

2024-1-1

The Efficacy and Safety of Anlotinib Plus Etoposide with Cisplatin/Carboplatin in the First-Line Treatment of Lung Cancer: A Phase II Clinical Study

2024-1-1

Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis

2024-1-1

Peripheral Blood Inflammatory Markers as A Reliable Predictor of Gastric Mucosal Metaplasia Change in the Middle-aged Population

2024-1-1

Determination of the Immunomodulatory Role of OTOP2 in Colon Adenocarcinoma

2024-1-1

Fluoxetine as a Potential Therapeutic Agent for Inhibiting Melanoma Brain and Lung Metastasis: Induction of Apoptosis, G0/G1 Cell Cycle Arrest, and Disruption of Autophagy Flux

2024-1-1

The prognostic and immune significance of PLBD1 in pan-cancer and its roles in proliferation and invasion of glioma

2024-1-1

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司